首页> 外国专利> Microparticles containing the CGRP-antagonist 1-N2-3,5-dibrom-N-4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinylcarbonyl-D-tyrosyl-L-lysyl-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder

Microparticles containing the CGRP-antagonist 1-N2-3,5-dibrom-N-4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinylcarbonyl-D-tyrosyl-L-lysyl-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder

机译:含有CGRP拮抗剂1- [N2- [3,5-dibrom-N-[[4-(3,4-二氢-2(1H)-氧喹唑啉-3-基)-1-哌啶基]羰基]- D-酪基] -L-赖氨酰] -4-(4-吡啶基)-哌嗪,其制备方法及其作为吸入粉的用途

摘要

The invention relates to inhalable powders in the form of stable, spray-dried microparticles (embedding particles) for pulmonary or nasal inhalation, containing the CGRP antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine (A) or a physiologically acceptable salt thereof and one or more excipients, processes for preparing such microparticles and the use thereof for preparing a powder inhalant for the treatment of headaches, migraine and cluster headache. embedded image
机译:本发明涉及稳定的喷雾干燥的微粒形式的可吸入粉末,用于肺或鼻吸入,其包含CGRP拮抗剂1- [N 2 -[3,5-二溴- N-[[4-(3,4-二氢-2(1H)-氧代喹唑啉-3-基)-1-哌啶基]羰基] -D-酪氨酰基] -L-赖氨酰] -4-(4-吡啶基)-哌嗪(A)或其生理学上可接受的盐和一种或多种赋形剂,制备此类微粒的方法及其在制备用于治疗头痛,偏头痛和丛集性头痛的粉末吸入剂中的用途。 <图像alt =“嵌入式图像” file =“ US20050042178A1-20050224-C00001.GIF” he =“ 42.42mm” id =“ EMI-C00001” imgContent =“ chem” imgFormat =“ GIF” wi =“ 75.27mm” />

著录项

  • 公开/公告号US2005042178A1

    专利类型

  • 公开/公告日2005-02-24

    原文格式PDF

  • 申请/专利权人 MICHAEL TRUNK;CLAUDIUS WEILER;

    申请/专利号US20040901791

  • 发明设计人 CLAUDIUS WEILER;MICHAEL TRUNK;

    申请日2004-07-29

  • 分类号A61K38/04;A61L9/04;A61K9/14;

  • 国家 US

  • 入库时间 2022-08-21 22:22:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号